Literature DB >> 33631539

Cardiac sympathetic denervation and mental health.

Sahib S Khalsa1, Ashley N Clausen2, Leila Shahabi3, Julie Sorg4, Sarah E Gonzalez4, Bruce Naliboff5, Kalyanam Shivkumar4, Olujimi A Ajijola4.   

Abstract

BACKGROUND: Bilateral cardiac sympathetic denervation (BCSD) is a surgical treatment for refractory ventricular arrhythmias. Although the procedure has shown efficacy at reducing cardiac arrhythmias, its impact on mental health is unknown. In the current study we examined associations between the BCSD procedure and mental health.
METHODS: 10 ventricular arrhythmia patients undergoing BCSD completed assessments of anxiety, depression, and posttraumatic stress symptoms at pre- and post-BCSD time points. Wilcoxon signed rank and Mann-Whitney U tests were used to examine differences in mental health symptoms in the pre- and post-BSCD states. Point biserial correlations were used to explore associations between BCSD response and mental health symptoms.
RESULTS: A significant reduction of anxiety symptoms was observed from pre- to post-BCSD. At the post-BCSD assessment, participants who successfully responded to the BCSD procedure exhibited lower anxiety symptoms compared to non-responders. However, no significant relationships were identified for depressive or PTSD symptoms.
CONCLUSION: The BCSD procedure is associated with reduced anxiety shortly after successful treatment for refractory ventricular arrhythmias in a small sample. Longitudinal surveillance of mental health symptoms after BCSD may be warranted to monitor the impact of this procedure on mental health.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Autonomic nervous system; Cardiac arrhythmia; Depression; Mental health; PTSD; Sympathectomy

Mesh:

Year:  2021        PMID: 33631539      PMCID: PMC8082676          DOI: 10.1016/j.autneu.2021.102787

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  50 in total

Review 1.  The hierarchical basis of neurovisceral integration.

Authors:  Ryan Smith; Julian F Thayer; Sahib S Khalsa; Richard D Lane
Journal:  Neurosci Biobehav Rev       Date:  2017-02-08       Impact factor: 8.989

Review 2.  Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care.

Authors:  Samuel E Sears; Jamie B Conti
Journal:  Clin Cardiol       Date:  2003-03       Impact factor: 2.882

3.  Depression, anxiety and 6-year risk of cardiovascular disease.

Authors:  Adrie Seldenrijk; Nicole Vogelzangs; Neeltje M Batelaan; Iris Wieman; Digna J F van Schaik; Brenda J W H Penninx
Journal:  J Psychosom Res       Date:  2014-10-22       Impact factor: 3.006

4.  Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: A systematic review.

Authors:  Rushil Shah; Fabrizio Assis; Navya Alugubelli; David R Okada; Rhanderson Cardoso; Kalyanam Shivkumar; Harikrishna Tandri
Journal:  Heart Rhythm       Date:  2019-06-25       Impact factor: 6.343

5.  The use of stellate ganglion block in the treatment of panic/anxiety symptoms with combat-related post-traumatic stress disorder; preliminary results of long-term follow-up: a case series.

Authors:  Sean W Mulvaney; Brian McLean; Jason de Leeuw
Journal:  Pain Pract       Date:  2010-04-20       Impact factor: 3.183

6.  Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?

Authors:  Joseph J Germano; Matthew Reynolds; Vidal Essebag; Mark E Josephson
Journal:  Am J Cardiol       Date:  2006-03-09       Impact factor: 2.778

7.  Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation.

Authors:  Eva R Serber; Samuel F Sears; Christopher D Nielsen; William H Spencer; Karen M Smith
Journal:  Am J Cardiol       Date:  2007-11-15       Impact factor: 2.778

8.  Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association.

Authors:  Sandra B Dunbar; Cynthia M Dougherty; Samuel F Sears; Diane L Carroll; Nathan E Goldstein; Daniel B Mark; George McDaniel; Susan J Pressler; Eleanor Schron; Paul Wang; Vicki L Zeigler
Journal:  Circulation       Date:  2012-09-24       Impact factor: 29.690

9.  Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?

Authors:  David A Barton; Tye Dawood; Elisabeth A Lambert; Murray D Esler; Deepak Haikerwal; Celia Brenchley; Florentia Socratous; David M Kaye; Markus P Schlaich; Ian Hickie; Gavin W Lambert
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

10.  Synergistic application of cardiac sympathetic decentralization and comprehensive psychiatric treatment in the management of anxiety and electrical storm.

Authors:  Sahib S Khalsa; Leila Shahabi; Olujimi A Ajijola; Alexander Bystritsky; Bruce D Naliboff; Kalyanam Shivkumar
Journal:  Front Integr Neurosci       Date:  2014-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.